Search Results - Kirkpatrick, Lynn
- Showing 1 - 6 results of 6
-
1
-
2
The PPARγ agonist pioglitazone prevents the hyperglycemia caused by phosphoinositide-3-kinase pathway inhibition by PX-866 without affecting antitumor activity by Ihle, Nathan T., Lemos, Robert, Schwartz, David, Oh, Junghwan, Halter, Robert J., Wipf, Peter, Kirkpatrick, Lynn, Powis, Garth
Published 2009Text -
3
Dynamic Contrast-Enhanced and Diffusion MRI Show Rapid and Dramatic Changes in Tumor Microenvironment in Response to Inhibition of HIF-1α Using PX-478 by Jordan, Bénédicte F, Runquist, Matthew, Raghunand, Natarajan, Baker, Amanda, Williams, Ryan, Kirkpatrick, Lynn, Powis, Garth, Gillies, Robert J
Published 2005Text -
4
Treatment with HIF-1α Antagonist PX-478 Inhibits Progression and Spread of Orthotopic Human Small Cell Lung Cancer and Lung Adenocarcinoma in Mice by Jacoby, Jörg J., Erez, Baruch, Korshunova, Maria V., Williams, Ryan R., Furutani, Kazuhisa, Takahashi, Osamu, Kirkpatrick, Lynn, Lippman, Scott M., Powis, Garth, O’Reilly, Michael S., Herbst, Roy S.
Published 2010Text -
5
An inhibitor of the pleckstrin homology domain of CNK1 selectively blocks the growth of mutant KRAS cells and tumors by Indarte, Martin, Puentes, Roisin, Maruggi, Marco, Ihle, Nathan T., Grandjean, Geoffrey, Scott, Michael, Ahmed, Zamal, Meuillet, Emmanuelle J., Zang, Shuxing, Lemos, Robert, Du-Cuny, Lei, Layng, Fabiana I. A. L., Correa, Ricardo G., Bankston, Laurie A., Liddington, Robert C., Kirkpatrick, Lynn, Powis, Garth
Published 2019Text -
6
PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancer by Jeung, Hei-Cheul, Puentes, Roisin, Aleshin, Alexander, Indarte, Martin, Correa, Ricardo G., Bankston, Laurie A., Layng, Fabiana I.A.L., Ahmed, Zamal, Wistuba, Ignacio, Yao, Yong, Duenas, Daniela G., Zhang, Shuxing, Meuillet, Emmanuelle J., Marassi, Francesca, Liddington, Robert C., Kirkpatrick, Lynn, Powis, Garth
Published 2021Text